PureTech Health (PRTC) Common Equity (2019 - 2025)

PureTech Health (PRTC) has 7 years of Common Equity data on file, last reported at $305.7 million in Q4 2025.

• Common Equity for Q4 2025 came in at $305.7 million, down 25.07% year-over-year; the trailing twelve-month figure through Dec 2025 was $305.7 million (down 25.07% YoY), and the FY2025 annual result was $305.7 million, down 25.07% from the prior year.
• Common Equity fell to $305.7 million in Q4 2025 per PRTC's latest filing, from $369.0 million in the prior quarter.
• Over five years, Common Equity peaked at $584.1 million in Q4 2021 and troughed at $305.7 million in Q4 2025.
• A 5-year average of $425.5 million and a median of $407.9 million in 2024 frame the typical range for Common Equity.
• On a YoY basis, Common Equity climbed as much as 20.52% in 2025 and fell as far as 25.07% in 2025.
• A 5-year view of Common Equity shows it stood at $584.1 million in 2021, then decreased by 6.26% to $547.6 million in 2022, then retreated by 16.32% to $458.2 million in 2023, then slipped by 10.98% to $407.9 million in 2024, then fell by 25.07% to $305.7 million in 2025.
• Business Quant data shows PRTC's Common Equity at $305.7 million in Q4 2025, $369.0 million in Q2 2025, and $407.9 million in Q4 2024.